Mayo Clinic expert offers perspective on experimental Alzheimer's disease drug

Daily Republic | Fairfield

Oct 9, 2022

According to drugmakers Eisai and Biogen, a Phase 3 clinical study on a potential new Alzheimer's disease drug shows promise. The study findings show that the drug, lecanemab, redu…